Atlas Trials

Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor

Clinical trial NCT05590689 · RECRUITING

Trial details

NCT number
NCT05590689
Sponsor
Universität Münster
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Glioblastoma
Start date
2022-11-09
Primary completion
2028-01-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.